शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans

This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →

BSENOVYRA PHARMACHEM LIMITED· Agricultural Food & other ProductsHighNeutral
Announced Mon, 2 Nov, 2026 · 17:51 IST

Revenue Rs 423.08 lakh vs Rs 1 lakh a year ago; standalone Sep 2026 quarter PAT loss Rs 3.32 lakh

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction

Awaiting price reaction for this filing.

AI summary

Revenue from operations was Rs 423.08 lakh in the standalone quarter ended September 30, 2026 versus Rs 1 lakh a year earlier; PAT was a Rs 3.32 lakh loss versus Rs 0.10 lakh profit. Operating EBITDA margin improved to about minus 1.6 percent from minus 214 percent on a low prior-year base. Standalone half year to Sep 30, 2026: revenue from operations Rs 595.69 lakh, PAT loss Rs 5.31 lakh, operating cash flow positive at Rs 49.84 lakh.

Likely market impact

Revenue surged and EBITDA margin improved sharply, but the quarter remained loss-making; positive half-year operating cash flow offers support.

By the numbersStandalone · Q2 FY27

The company's XBRL figures for this quarter look filed in the wrong unit: revenue reads ₹4.23 Cr against ₹0.03 Cr a year ago, about 128× larger. A move that size is almost always a wrong unit, not a business, so nothing is computed from these figures and no number-based tags are set; the read above is the AI's, from the document.